Skip to main content
SpringerLink
Log in

Metabolic reprogramming in osteoclasts

  • Review
  • Published:
Seminars in Immunopathology Aims and scope Submit manuscript

Abstract

Osteoclasts are bone-resorbing cells that play an essential role in the remodeling of the bone. Defects in osteoclasts thus result in unbalanced bone remodeling, leading to numerous pathological conditions such as osteoporosis, bone metastasis, and inflammatory bone erosion. Metabolism is any process a cell utilizes to meet its energetic demand for biological functions. Along with signaling pathways and osteoclast-specific gene expression programs, osteoclast differentiation activates metabolic programs. The energy generated from metabolic reprogramming in osteoclasts not only supports the phenotypic changes from mononuclear precursor cells to multinuclear osteoclasts, but also facilitates bone resorption, a major function of terminally differentiated, mature osteoclasts. While oxidative phosphorylation is studied as a major metabolic pathway that fulfills the energy demands of osteoclasts, all metabolic pathways are closely interconnected. Therefore, it remains important to understand the various aspects of osteoclast metabolism, including the roles and effects of glycolysis, glutaminolysis, fatty acid synthesis, and fatty acid oxidation. Targeting the pathways associated with metabolic reprogramming has shown beneficial effects on pathological conditions. As a result, it is clear that a deeper understanding of metabolic regulation in osteoclasts will offer broader translational potential for the treatment of human bone disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ikeda K, Takeshita S (2016) The role of osteoclast differentiation and function in skeletal homeostasis. J Biochem 159(1):1–8

    Article  CAS  PubMed  Google Scholar 

  2. Nakashima T, Hayashi M, Takayanagi H (2012) New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab 23(11):582–590

    Article  CAS  PubMed  Google Scholar 

  3. Boyce BF (2013) Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts. J Bone Miner Res 28(4):711–722

    Article  CAS  PubMed  Google Scholar 

  4. Fuller K, Kirstein B, Chambers TJ (2007) Regulation and enzymatic basis of bone resorption by human osteoclasts. Clin Sci (Lond) 112(11):567–575

    Article  CAS  Google Scholar 

  5. Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4(8):638–649

    Article  CAS  PubMed  Google Scholar 

  6. Feldenberg LR, Thevananther S, del Rio M, de Leon M, Devarajan P (1999) Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am J Phys 276(6):F837–F846

    CAS  Google Scholar 

  7. Spinelli JB, Haigis MC (2018) The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol 20(7):745–754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Eisner V, Picard M, Hajnoczky G (2018) Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat Cell Biol 20(7):755–765

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dudley HR, Spiro D (1961) The fine structure of bone cells. J Biophys Biochem Cytol 11(3):627–649

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15(3):259–266

    Article  CAS  PubMed  Google Scholar 

  11. Wei W, Wang X, Yang M, Smith LC, Dechow PC, Sonoda J, Evans RM, Wan Y (2010) PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab 11(6):503–516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Wan Y (2010) PPARgamma in bone homeostasis. Trends Endocrinol Metab 21(12):722–728

    Article  CAS  PubMed  Google Scholar 

  13. Wei W, Schwaid AG, Wang X, Wang X, Chen S, Chu Q, Saghatelian A, Wan Y (2016) Ligand activation of ERRalpha by cholesterol mediates statin and bisphosphonate effects. Cell Metab 23:479–491

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zeng R, Faccio R, Novack DV (2015) Alternative NF-kappaB regulates RANKL-induced osteoclast differentiation and mitochondrial biogenesis via independent mechanisms. J Bone Miner Res 30(12):2287–2299

    Article  CAS  PubMed  Google Scholar 

  15. Izawa T, Rohatgi N, Fukunaga T, Wang QT, Silva MJ, Gardner MJ, McDaniel ML, Abumrad NA, Semenkovich CF, Teitelbaum SL, Zou W (2015) ASXL2 regulates glucose, Lipid, and Skeletal Homeostasis. Cell Rep 11(10):1625–1637

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wilson L, Yang Q, Szustakowski JD, Gullicksen PS, Halse R (2007) Pyruvate induces mitochondrial biogenesis by a PGC-1 alpha-independent mechanism. Am J Phys Cell Phys 292(5):C1599–C1605

    CAS  Google Scholar 

  17. Drosatos-Tampakaki Z, Drosatos K, Siegelin Y, Gong S, Khan S, Van Dyke T, Goldberg IJ, Schulze PC, Schulze-Spate U (2014) Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it. J Bone Miner Res 29(5):1183–1195

    Article  CAS  PubMed  Google Scholar 

  18. Falkenberg M, Gaspari M, Rantanen A, Trifunovic A, Larsson NG, Gustafsson CM (2002) Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet 31(3):289–294

    Article  CAS  PubMed  Google Scholar 

  19. Miyazaki T, Iwasawa M, Nakashima T, Mori S, Shigemoto K, Nakamura H, Katagiri H, Takayanagi H, Tanaka S (2012) Intracellular and extracellular ATP coordinately regulate the inverse correlation between osteoclast survival and bone resorption. J Biol Chem 287(45):37808–37823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bae S, Lee MJ, Mun SH, Giannopoulou EG, Yong-Gonzalez V, Cross JR, Murata K, Giguere V, van der Meulen M, Park-Min KH (2017) MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRalpha. J Clin Invest 127(7):2555–2568

    Article  PubMed  PubMed Central  Google Scholar 

  21. Nishikawa K, Iwamoto Y, Kobayashi Y, Katsuoka F, Kawaguchi S, Tsujita T, Nakamura T, Kato S, Yamamoto M, Takayanagi H, Ishii M (2015) DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway. Nat Med 21(3):281–287

    Article  CAS  PubMed  Google Scholar 

  22. Lemma S, Sboarina M, Porporato PE, Zini N, Sonveaux P, Di Pompo G, Baldini N, Avnet S (2016) Energy metabolism in osteoclast formation and activity. Int J Biochem Cell Biol 79:168–180

    Article  CAS  PubMed  Google Scholar 

  23. Jin Z, Wei W, Yang M, Du Y, Wan Y (2014) Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metab 20(3):483–498

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lunt SY, Vander Heiden MG (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27:441–464

    Article  CAS  PubMed  Google Scholar 

  25. Karner CM, Long F (2018) Glucose metabolism in bone. Bone 115:2–7

    Article  CAS  PubMed  Google Scholar 

  26. Indo Y, Takeshita S, Ishii KA, Hoshii T, Aburatani H, Hirao A, Ikeda K (2013) Metabolic regulation of osteoclast differentiation and function. J Bone Miner Res 28(11):2392–2399

    Article  CAS  PubMed  Google Scholar 

  27. Chen LQ, Cheung LS, Feng L, Tanner W, Frommer WB (2015) Transport of sugars. Annu Rev Biochem 84:865–894

    Article  CAS  PubMed  Google Scholar 

  28. Palazon A, Goldrath AW, Nizet V, Johnson RS (2014) Review HIF transcription factors, inflammation, and immunity. Immunity 41:518–528

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Murata K, Fang C, Terao C, Giannopoulou EG, Lee YJ, Lee MJ, Mun SH, Bae S, Qiao Y, Yuan R, Furu M, Ito H, Ohmura K, Matsuda S, Mimori T, Matsuda F, Park-Min KH, Ivashkiv LB (2017) Hypoxia-sensitive COMMD1 integrates signaling and cellular metabolism in human macrophages and suppresses osteoclastogenesis. Immunity 47(1):66–79 e5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Miyauchi Y, Sato Y, Kobayashi T, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Morioka H, Matsumoto M, Chambon P, Johnson RS, Kato S, Toyama Y, Miyamoto T (2013) HIF1alpha is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis. Proc Natl Acad Sci U S A 110(41):16568–16573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Knowles HJ, Athanasou NA (2009) Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis. J Pathol 218:256–264

    Article  CAS  PubMed  Google Scholar 

  32. Knowles HJ, Cleton-Jansen A-M, Korsching E, Athanasou NA (2010) Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB J 24:4648–4659

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Morten KJ, Badder L, Knowles HJ (2013) Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J Pathol 229:755–764

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Miyauchi Y, Sato Y, Kobayashi T, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Miyamoto K, Tando T, Morioka H, Matsumoto M, Chambon P, Johnson RS, Kato S, Toyama Y, Miyamoto T (2013) HIF1 α is required for osteoclast activation by estrogen de fi ciency in postmenopausal osteoporosis. Proc Natl Acad Sci 110:16568–16573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Leger AJ, Altobelli A, Mosquea LM, Belanger AJ, Song A, Cheng SH, Jiang C, Yew NS (2010) Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine. J Bone Miner Metab 28(5):510–519

    Article  CAS  PubMed  Google Scholar 

  36. Denko NC (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8(9):705–713

    Article  CAS  PubMed  Google Scholar 

  37. Ahn H, Lee K, Kim JM, Kwon SH, Lee SH, Lee SY, Jeong D (2016) Accelerated lactate dehydrogenase activity potentiates osteoclastogenesis via NFATc1 signaling. PLoS One 11(4):e0153886

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Saxton RA, Sabatini DM (2017) mTOR signaling in growth, Metabolism, and Disease. Cell 168(6):960–976

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Chen J, Long F (2018) mTOR signaling in skeletal development and disease. Bone Res 6:1

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA (2003) M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ 10(10):1165–1177

    Article  CAS  PubMed  Google Scholar 

  41. Tiedemann K, Le Nihouannen D, Fong JE, Hussein O, Barralet JE, Komarova SV (2017) Regulation of osteoclast growth and fusion by mTOR/raptor and mTOR/rictor/Akt. Front Cell Dev Biol 5:54

    Article  PubMed  PubMed Central  Google Scholar 

  42. Huynh H, Wan Y (2018) mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1. Commun Biol 1:29

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Dai Q, Xie F, Han Y, Ma X, Zhou S, Jiang L, Zou W, Wang J (2017) Inactivation of regulatory-associated protein of mTOR (raptor)/mammalian target of rapamycin complex 1 (mTORC1) signaling in osteoclasts increases bone mass by inhibiting osteoclast differentiation in mice. J Biol Chem 292(1):196–204

    Article  CAS  PubMed  Google Scholar 

  44. Wu H, Wu Z, Li P, Cong Q, Chen R, Xu W, Biswas S, Liu H, Xia X, Li S, Hu W, Zhang Z, Habib SL, Zhang L, Zou J, Zhang H, Zhang W, Li B (2017) Bone size and quality regulation: concerted actions of mTOR in mesenchymal stromal cells and osteoclasts. Stem Cell Reports 8(6):1600–1616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Tintut Y, Morony S, Demer LL (2004) Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 24(2):e6–e10

  46. Kim SP, Li Z, Zoch ML, Frey JL, Bowman CE, Kushwaha P, Ryan KA, Goh BC, Scafidi S, Pickett JE, Faugere MC, Kershaw EE, Thorek DLJ, Clemens TL, Wolfgang MJ, Riddle RC (2017) Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner. JCI Insight 2(16)

  47. D.M.A. P.K.LUND, and J.C. MATHI, Lipid composition of normal human bone marrow as determined by column chromatography, Journal of Lipid Resesrch 3(1) (1962)

  48. Kasonga AE, Deepak V, Kruger MC, Coetzee M (2015) Arachidonic acid and docosahexaenoic acid suppress osteoclast formation and activity in human CD14+ monocytes, in vitro. PLoS One 10(4):e0125145

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G (2003) Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18(7):1206–1216

    Article  CAS  PubMed  Google Scholar 

  50. Mangano KM, Sahni S, Kerstetter JE, Kenny AM, Hannan MT (2013) Polyunsaturated fatty acids and their relation with bone and muscle health in adults. Curr Osteoporos Rep 11(3):203–212

    Article  PubMed  Google Scholar 

  51. Oh SR, Sul OJ, Kim YY, Kim HJ, Yu R, Suh JH, Choi HS (2010) Saturated fatty acids enhance osteoclast survival. J Lipid Res 51(5):892–899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Li JY, Chassaing B, Tyagi AM, Vaccaro C, Luo T, Adams J, Darby TM, Weitzmann MN, Mulle JG, Gewirtz AT, Jones RM, Pacifici R (2016) Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest 126(6):2049–2063

    Article  PubMed  PubMed Central  Google Scholar 

  53. Correa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA (2016) Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol 5(4):e73

    Article  CAS  Google Scholar 

  54. Lucas S, Omata Y, Hofmann J, Bottcher M, Iljazovic A, Sarter K, Albrecht O, Schulz O, Krishnacoumar B, Kronke G, Herrmann M, Mougiakakos D, Strowig T, Schett G, Zaiss MM (2018) Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun 9(1):55

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS (2008) Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 8(6):512–521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286(5446):1946–1949

    Article  CAS  PubMed  Google Scholar 

  57. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RV Jr (2000) Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 25(1):87–90

    Article  CAS  PubMed  Google Scholar 

  58. Sato T, Morita I, Murota S (1998) Involvement of cholesterol in osteoclast-like cell formation via cellular fusion. Bone 23(2):135–140

    Article  CAS  PubMed  Google Scholar 

  59. Okayasu M, Nakayachi M, Hayashida C, Ito J, Kaneda T, Masuhara M, Suda N, Sato T, Hakeda Y (2012) Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion. J Biol Chem 287(23):19229–19241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Luegmayr E, Glantschnig H, Wesolowski GA, Gentile MA, Fisher JE, Rodan GA, Reszka AA (2004) Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ 11(Suppl 1):S108–S118

    Article  CAS  PubMed  Google Scholar 

  61. Ryu J, Kim H, Chang EJ, Kim HJ, Lee Y, Kim HH (2010) Proteomic analysis of osteoclast lipid rafts: the role of the integrity of lipid rafts on V-ATPase activity in osteoclasts. J Bone Miner Metab 28(4):410–417

    Article  CAS  PubMed  Google Scholar 

  62. Wellen KE, Thompson CB (2012) A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 13(4):270–276

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Figures are created with BioRender.com.

Funding

This work was supported by grants from the N.I.H. (R01AR069562 and R01 AR073156-01), by Weill Cornell CTSC, and by support for the Rosensweig Genomics Center from The Tow Foundation.

Author information

Authors and Affiliations

  1. Arthritis and Tissue Degeneration Program, David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA

    Kyung-Hyun Park-Min

  2. Department of Medicine, Weill Cornell Medical College, New York, NY, 10065, USA

    Kyung-Hyun Park-Min

  3. BCMB Allied Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, 10021, USA

    Kyung-Hyun Park-Min

Authors
  1. Kyung-Hyun Park-Min
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kyung-Hyun Park-Min.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

This article is a contribution to the special issue on Osteoimmunology - Guest Editor: Mary Nakamura

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park-Min, KH. Metabolic reprogramming in osteoclasts. Semin Immunopathol 41, 565–572 (2019). https://doi.org/10.1007/s00281-019-00757-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00281-019-00757-0

Keywords

Search

Navigation